Ivacaftor
VX08-770-103
Phase 3 small_molecule completed
Quick answer
Ivacaftor for Cystic Fibrosis is a Phase 3 program (small_molecule) at VERTEX PHARMACEUTICALS INC / MA with 16 ClinicalTrials.gov record(s).
Program details
- Company
- VERTEX PHARMACEUTICALS INC / MA
- Indication
- Cystic Fibrosis
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed